Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» June 2011
June 2011
Amgen seeks FDA OK to use Xgeva to prevent, delay prostate cancer spread to bones
Amgen seeks FDA OK to use Xgeva to prevent, delay prostate cancer spread to bones
Yahoo/AP
Amgen
Xgeva
prostate cancer
Amgen Sells $3 Billion of Bond to Fund Stock Dividend Payments
Amgen Sells $3 Billion of Bond to Fund Stock Dividend Payments
Bloomberg
Amgen
dividends
bonds
Novo Nordisk Likely to Profit From Worldwide Growth in Diabetic Treatments
Novo Nordisk Likely to Profit From Worldwide Growth in Diabetic Treatments
Seeking Alpha
diabetes
Novo Nordisk
Shire to Produce More Replagal
Shire to Produce More Replagal
Yahoo/Zacks.com
Shire
Replagal
Sanofi
Fabry's disease
How Does Affymetrix Really Boost Its Returns?
How Does Affymetrix Really Boost Its Returns?
Motley Fool
Affymetrix
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Seeking Alpha
FDA
Durect Corporation
Pain Therapeutics
Acura Pharmaceuticals
Lannett
Fibrocell Science
J&J to link up product marketing
J&J to link up product marketing
FT.com
JNJ
marketing
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Brilinta
AstraZeneca
aspirin
Plavix
Sanofi
Bristol-Myers Squibb
Pleasure And Pain For Pfizer
Pleasure And Pain For Pfizer
Investopedia
Pfizer
Pain Therapeutics
Durect Corporation
JNJ
Abbott Laboratories
Acura Pharmaceuticals
Biotech Clinical Trials Update for 3 Drug Manufacturers
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Pfizer
Cel-Sci
Bristol-Myers Squibb
Eliquis
Multikine
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »